Series A Biotechnology Companies

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets.

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Phyla is developing alternative therapies for antibiotics.

True precision medicine through single-cell science

Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.

Mytos is building a fully-automated cell manufacture platform for Pharma

Ryp Labs develops and commercializes technologies designed to reduce food waste.

Nova Pangaea Technologies is a cleantech company that has developed a sustainable technology called REFNOVA

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.